Remedium Bio raises $10 million to develop adjustable gene therapy for chronic diseases
Longevity Technology - 10-Aug-2026The experimental approach could allow doctors to change treatment levels later
Eleanor Garth
Staff Writer and Community Manager, Longevity Technology
Following a degree in Classics, Eleanor organised biomedical engineering conferences and provided research support at Imperial College London and various London hospitals, before working as a science and medicine journalist.
Visit website: https://www.longevity.technology/author/eleanor/
See also
Longevity Technology
Daily news and insights on research, investments and technologies on life extension
Details last updated 03-Jun-2020
Eleanor Garth is also referenced in the following:
Citizens Science and Your Longevity
26-Feb-2022
Online webinar about science and longevity organized by Coalition for Radical Life Extension moderated by Dr. Greg Fahy (FREE)
Articles written by Eleanor Garth
Neko health raises $700 million to scale preventive healthcare in the US
Longevity Technology - 16-Jul-2026Technology combines health scans and data to spot potential health risks before symptoms appear
Rare disease breakthrough could unlock new treatments for ageing
Longevity Technology - 29-Jun-2026Calico's experimental drug targets a key cellular stress pathway
Celularity banks $12m to refocus its longevity ambitions
Longevity Technology - 19-Dec-2025New funding gives the regenerative biotech breathing space to prioritise placental cell therapies
Lilly expands $100M AI drug discovery deal with Insilico Medicine
Longevity Technology - 11-Nov-2025Insilico’s AI cut drug discovery to 18 months, spurring Lilly’s investment
The Cat Health Company raises $1.2m to extend feline healthspan
Longevity Technology - 08-Oct-2025Interim trials show improved weight, muscle, and vitality in aging cats with TCHC therapies
A brighter path for Parkinson’s: light therapy device nears FDA finish line
Longevity Technology - 28-Apr-2025PhotoPharmics secures $6 million to advance its home-based Celeste device
Nuritas raised $42M to expand AI-driven peptide discovery for sustainable solutions
Longevity Technology - 23-Dec-2024Their platform speeds up finding peptides from plants, making healthcare solutions faster
OneSkin raises $20m to revolutionize anti-ageing skincare
Longevity Technology - 14-Nov-2024A science-backed approach to healthier, younger-looking skin
International Institute of Longevity relaunches to set global standards for longevity clinics
Longevity Technology - 17-Oct-2024They aim to improve patient care and make clinics more trustworthy and effective
Two longevity organisations join forces to tackle the biology of ageing
Longevity Technology - 09-Oct-2024SENS and Lifespan.io unite research and public outreach under one roof
The Cat Health Company secures funding to transform feline longevity
Longevity Technology - 24-Sep-2024Innovative partnerships aim to develop groundbreaking therapeutics for age-related diseases in cats
Montara Therapeutics raises $8M to develop brain-targeted drugs
Longevity Technology - 01-Aug-2024Approach is based on research from UCSF and could transform how diseases are treated
BioXtek pioneers new regenerative therapies with human birth tissue
Longevity Technology - 17-Jul-2024Unlocks the healing power of placentas for wound care, anti-aging, and beyond
TruDiagnostic launches a novel epigenetic ageing test to analyse 11 organs
Longevity Technology - 28-Jun-2024Findings indicate that each organ system has its unique ageing trajectory
BrainBridge is working on a way to transplant a person's head onto a new body
Longevity Technology - 21-May-2024This could potentially revolutionize treatment for severe conditions
Hevolution invests $20 million in Aeovian Pharmaceuticals to fight ageing
Longevity Technology - 28-Mar-2024Funds to advance compounds that target mTORC1 pathway for treating rare and age-related conditions
SENISCA secures 3.7 million euros to fight aging with RNA-based therapies
Longevity Technology - 18-Mar-2024Developing senotherapeutics to target cellular senescence and treat age-related diseases
Tagomics secures 6.7M euros to revolutionize disease diagnosis with multiomics
Longevity Technology - 21-Feb-2024Unlocking a new era of comprehensive disease insights and treatment strategies
GlycanAge raises $4.2M to develop disease-detecting blood tests using sugar molecules
Longevity Technology - 19-Feb-2024Company aims to transform healthcare by using cutting-edge sugar-based diagnostics
Display all articles
